A Mediterranean-style, low-glycemic-load diet reduces the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mononuclear cells and plasma insulin in women with metabolic syndrome

Nutrition Research

Volumn 31, Issue 9, 2011, Pages 659-664

  Jones, Jennifer L ^a   Park, Youngki ^a   Lee, Jiyoung ^a   Lerman, Robert H ^b   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b MetaProteomics LLC   (United States)

Author keywords

Gene expression; Inflammation; Insulin; Mediterranean diet; Metabolic syndrome; Women

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LOW GLYCEMIC LOAD DIET; MEDITERRANEAN DIET; METABOLIC SYNDROME X; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD GLUCOSE; CHOLESTEROL, LDL; DIET, MEDITERRANEAN; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INSULIN; METABOLIC SYNDROME X; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LDL; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 82555204720     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.08.011     Document Type: Article

References (40)

1. Graves B.W. The obesity epidemic: scope of the problem and management strategies. J Midwifery Womens Health 2010, 55:568-578.
2. Potenza M.V., Mechanick J.I. The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract 2009, 24:560-577.
3. Lyssenko V., Sjögren M., Almgren P. Genetic prediction of the metabolic syndrome. Diabet Metabolic Syndr: Clini Res Rev 2008, 2:245-252.
4. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006, 21:1-6.
5. Lusis A.J., Attie A.D., Reue K. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 2008, 9:819-830.
6. Manolio T.A. Cohort studies and the genetics of complex disease. Nat Genet 2009, 41:5-6.
7. Singh B., Saxena A. Surrogate markers of insulin resistance. World J Diab 2010, 15:36-47.
8. Belleh E. Health and lifestyle benefits from adherence to the Mediterranean diet. J Cons Health Int 2010, 14:75-80.
9. Babio N., Bulló M., Salas-Salvadó J. Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr 2009, 12(9 SPEC. ISSUE 9A):1607-1617.
10. Esposito K., Ciotola M., Giugliano D. Mediterranean diet and the metabolic syndrome. Molec Nutr Food Res 2007, 51:1268-1274.
11. Konstantinidou V., Covas M.I., Muñoz-Aguayo D., Khymenets O., de La Torre R., Saez G., Tomos Mdel C., et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J 2010, 24:2546-2557.
12. Perez-Martinez P., Lopez-Miranda J., Blnco-Colio L., Bellido C., Jimenez Y., Moreno J.A., Delgado-Lista J., Egido J., Perez-Jimenez F. The chronic intake of a Mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor B activation in peripheral blood mononuclear cells from healthy men. Atherosclerosis 2007, 194:e141-e146.
13. Llorente-Cortés V., Estruch R., Mena M.P., Ros E., Gonzalez M.A., Fito M., Lamuela-Raventos R.M., Badimon L. Effect of Mediterranean diet on the expression of pro-atherogenic genes in a population at high cardiovascular risk. Atherosclerosis 2010, 208:442-450.
14. Camargo A., Ruano J., Fernandez J.M., Parnell L.D., Jimenez A Gonzalez M., Marin C., Perez-Martinez P., Uceda M., Lopez-Miranda J., Perez-Jimenez F. Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics 2010, 11(1).
15. Aggarwal D., Soliman G., Freake H.C., Dutta A., Fernandez M.L. Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism. Lipids Health Dis 2006, 5.
16. Powell E.E., Kroon P.A. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J Clin Invest 1994, 93:2168-2174.
17. Jones J.L., Fernandez M.L., McIntosh M., Najm W., Calle M.C., Kallynych C., Vukich C., Barona J., Ackermann D., Kim J.E., Kumar V., Lott M., Volek J.S., Lerman R.H. A Mediterranean-style low-glycemic-load diet improves variables of metabolic syndrome in women, and addition of a phytochemical-rich medical food enhances benefits on lipoprotein metabolism. J Clin Lipidol 2011, 5:188-196.
18. Dieckmann M., Dietrich M.F., Herz J. Lipoprotein receptors-an evolutionarily ancient multifunctional receptor family. Biolog Chem 2010, 391:1341-1363.
19. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
21. Grundy S.M., Hansen B., Smith S.C., Leeman J.I., Kahn R.A. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on scientific issues related to management. Circulation 2004, 109:551-556.
22. Schiltz B., Minich D.M., Lerman R.G., Lamb J.J., Tripp M.L., Bland J.S.A. Science-based, clinically tested dietary approach for the metabolic syndrome. Metabolic Syndr Relat Disord 2009, 7:187-192.
23. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
24. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968, 97:77-89.
25. Park Y.K., Rasmussen H.E., Ehlers S.J., Blobaum K.R., Lu F., Schlegal V.R., Carr T.P., Lei J.Y. Repression of proinflammatory gene expression by lipid extract of Nostoc commune var sphaeroides Kutzing, a blue-green alga, via inhibition of nuclear factor-kappa B in RAW 264.7 macrophages. Nutr Res 2008, 28:83-92.
26. Rasmussen H.E., Blobaum K.R., Park K.Y., Ehlers S.J., Lu F., Lei K.Y. Lipid extract of Nostoc commune var. sphaeroides Kutzing, a blue-green alga, inhibits the activation of sterol regulatory element binding proteins in HepG2 cells. J Nutr 2008, 138:476-481.
27. Davidson M.H. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time. J Fam Prac 2009, 58(11 Suppl Urgent):S26-31.
28. Wilson P.W.F. Assessing coronary heart disease risk with traditional and novel risk factors. Clin Cardiol 2004, 27:III7-III11.
29. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol, Diabet Obes 2011, 18:39-143.
30. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: Direct and indirect effects of tumor necrosis factor-α. Cytokine Growth Factor Rev 2003, 14:447-455.
31. Benito M. Tissue specificity on insulin action and resistance: past to recent mechanisms. Acta Physiol 2011, 201:297-312.
32. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Rev 2000, 21(6):697-738.
33. Mutungi G., Torres-Gonzalez M., McGrane M.M., Volek J.S., Fernandez M.L. Carbohydrate restriction and dietary cholesterol modulate the expression of HMG-CoA reductase and the LDL receptor in mononuclear cells from adult men. Lipids Health Dis 2007, 6.
34. Patalay M., Lofgren I.E., Freake H.C., Koo S.I., Fernandez M.L. The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase. J Nutr 2005, 135:735-739.
35. Roberts C.K., Liang K., Barnard R.J., Kim C.H., Vaziri N.D. HMG-CoA reductase, cholesterol 7-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X. Kidney Int 2004, 66:1503-1511.
36. Dong X.Y., Tang S.Q. Insulin-induced gene: a new regulator in lipid metabolism. Peptides 2010, 31:2145-2150.
37. Kamagate A., Dong H.H. FoxO1 integrates insulin signaling to VLDL production. Cell Cycle 2008, 7:3162-3170.
38. Dallinga-Thie G.M., Dullaart R.P., van Tol A. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins. Curr Opin Lipidol 2007, 18:251-257.
39. Adiels M., Boren J., Caslake M.J., Stewart P., Soro A., Westerbacka J., Wennberg B., Olofsson S.O., Packard C., Taskinen M.R. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005, 25:1697-1703.
40. Berneis K.K., Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002, 43:1363-1379.